Femasys Inc. Increase (Decrease) in Accrued Liabilities
Femasys Inc. (FEMY) reported Increase (Decrease) in Accrued Liabilities of -$184.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- Femasys Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $9.01K.
- Femasys Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$193.23K, a 1104.35% decline year-over-year.
- Femasys Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $597.31K, a 84.70% increase year-over-year.
- Femasys Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$24.29K, a 110.07% decline year-over-year.
- Femasys Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $474.72K, a 6929.82% increase from fiscal 2024.
- Femasys Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $6.75K, a 99.32% decline from fiscal 2023.
- Femasys Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $987.58K.
- Femasys Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$147.07K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$184.22K 10-Q · filed 2026-08-14 | $413.09K derived: sum of 3 quarters · filed 2026-08-14 | $388.80K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$193.23K 10-Q · filed 2026-05-08 | $404.09K derived: sum of 2 quarters · filed 2026-05-08 | $379.80K derived: sum of 3 quarters · filed 2026-05-08 | $262.26K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $597.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $573.02K derived: sum of 2 quarters · filed 2026-03-31 | $455.49K derived: sum of 3 quarters · filed 2026-08-14 | $474.72K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$24.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$141.83K derived: sum of 2 quarters · filed 2026-08-14 | -$122.59K 10-Q · filed 2025-11-14 | $200.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$117.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$98.30K 10-Q · filed 2026-08-14 | $225.11K derived: sum of 3 quarters · filed 2026-08-14 | $466.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $19.24K 10-Q · filed 2026-05-08 | $342.64K derived: sum of 2 quarters · filed 2026-05-08 | $583.94K derived: sum of 3 quarters · filed 2026-05-08 | $818.23K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $323.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $564.70K derived: sum of 2 quarters · filed 2026-03-31 | $798.99K derived: sum of 3 quarters · filed 2026-03-31 | $6.75K 10-K · filed 2026-03-31 |
| 2024-09-30 | $241.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $475.59K derived: sum of 2 quarters · filed 2025-11-14 | -$316.65K 10-Q · filed 2025-11-14 | $558.20K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $234.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$557.94K 10-Q · filed 2025-08-08 | $316.91K derived: sum of 3 quarters · filed 2025-08-08 | $349.52K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$792.24K 10-Q · filed 2025-05-08 | $82.61K derived: sum of 2 quarters · filed 2025-05-08 | $115.23K derived: sum of 3 quarters · filed 2025-05-08 | $116.64K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $874.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $907.47K derived: sum of 2 quarters · filed 2025-03-27 | $908.88K derived: sum of 3 quarters · filed 2025-03-27 | $987.58K 10-K · filed 2025-03-27 |
| 2023-09-30 | $32.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $34.02K derived: sum of 2 quarters · filed 2024-11-12 | $112.73K 10-Q · filed 2024-11-12 | -$80.17K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $80.12K 10-Q · filed 2024-08-08 | -$112.78K derived: sum of 3 quarters · filed 2024-08-08 | $10.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $78.70K 10-Q · filed 2024-05-09 | -$114.20K derived: sum of 2 quarters · filed 2024-05-09 | $8.59K derived: sum of 3 quarters · filed 2024-05-09 | -$29.81K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$192.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$70.11K derived: sum of 2 quarters · filed 2024-03-28 | -$108.51K derived: sum of 3 quarters · filed 2024-03-28 | -$147.07K 10-K · filed 2024-03-28 |
| 2022-09-30 | $122.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $84.39K derived: sum of 2 quarters · filed 2023-11-14 | $45.83K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$38.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$76.96K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$38.56K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$504.80K 10-K/A · filed 2023-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |